Related Experiment Videos

[Carbapenem restriction reduce the incidence of multidrug-resistant Acinetobacter baumannii in ventilator associated

Xin-sheng Xue1, Bo Wang, Li-jing Deng

  • 1Department of Intensive Care Unit, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue = Chinese Critical Care Medicine = Zhongguo Weizhongbing Jijiuyixue
|April 21, 2009
PubMed
Abstract

Insights

Restricting carbapenem use significantly lowered multidrug-resistant Acinetobacter baumannii incidence in ventilator-associated pneumonia (VAP). This demonstrates carbapenem stewardship

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Antimicrobial Stewardship

Background:

  • Ventilator-associated pneumonia (VAP) is a significant hospital-acquired infection.
  • Multidrug-resistant (MDR) Acinetobacter baumannii poses a growing threat in intensive care units.
  • Carbapenem antibiotics are crucial for treating severe bacterial infections but their overuse drives resistance.

Purpose of the Study:

  • To investigate the impact of carbapenem restriction on MDR Acinetobacter baumannii incidence in VAP patients.
  • To analyze the correlation between carbapenem consumption and MDR Acinetobacter baumannii rates.

Main Methods:

  • A randomized controlled trial involving 26 VAP patients in an intensive care unit.
  • Patients were divided into a conventional care group and a carbapenem restriction group.
  • Sputum samples were collected, and carbapenem consumption was monitored.

Main Results:

  • The carbapenem restriction group showed a significantly lower incidence of MDR Acinetobacter baumannii (10.7%) compared to the conventional group (17.8%).
  • Carbapenem consumption was substantially reduced in the restriction group (61 g vs. 188 g).
  • A statistically significant correlation (P<0.05) was observed between reduced carbapenem use and decreased MDR Acinetobacter baumannii.

Conclusions:

  • Carbapenem restriction is an effective strategy to reduce the incidence of MDR Acinetobacter baumannii in VAP.
  • Antimicrobial stewardship programs incorporating carbapenem limitation can mitigate resistance.
  • This approach is vital for preserving the efficacy of carbapenems in critical care settings.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: